National Center for Research Resources; Notice of Closed Meetings, 13006 [E8-4565]

Download as PDF 13006 Federal Register / Vol. 73, No. 48 / Tuesday, March 11, 2008 / Notices Send comments to Susan G. Queen, Ph.D., HRSA Reports Clearance Officer, Room 10–33 Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857. Written comments should be received within 60 days of this notice. Dated: March 4, 2008. Alexandra Huttinger, Director, Division of Policy Review and Coordination. [FR Doc. E8–4787 Filed 3–10–08; 8:45 am] BILLING CODE 4165–15–P Dated: March 4, 2008. Amy P. Patterson, Director, Office of Biotechnology Activities. [FR Doc. E8–4849 Filed 3–10–08; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health yshivers on PROD1PC62 with NOTICES Office of the Director, National Institutes of Health; Office of Biotechnology Activity; Recombinant DNA Research; Notice of a Meeting of an NIH Blue Ribbon Panel There will be a meeting of the NIH Blue Ribbon Panel to advise on the Risk Assessment of the National Emerging Infectious Disease Laboratory at Boston University Medical Center. The meeting will be held on Thursday, March 13, 2008, at the National Institutes of Health, Building 1, Wilson Hall, 1 Center Drive, Bethesda, Maryland 20892, from 8:30 a.m. to approximately 2 p.m. Discussion will include the charge to the Panel, an overview of the principles of environmental protection laws, and risk assessment studies. For further information concerning this meeting contact Ms. Laurie Lewallen, Advisory Committee Coordinator, Office of Biotechnology Activities, Office of the Director, National Institutes of Health, 6705 Rockledge Drive, Room 750, Bethesda, MD 20892–7985, 301–496–9838, lewallla@od.nih.gov. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed above in advance of the meeting. Any interested person may file written comments with the panel by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be VerDate Aug<31>2005 15:44 Mar 10, 2008 Jkt 214001 inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. An agenda and any additional information for the meeting will be posted on the agency’s Web site: https://www.nih.gov/about/director/acd/ index.htm. Background information may be obtained by contacting NIH OBA by email oba@od.nih.gov. BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agenda: To review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Room 1068, Bethesda, MD 20892. (Telephone Conference Call) Contact Person: John R. Glowa, PhD, Scientific Review Officer, National Center for Research Resources, or National Institutes of Health, 6701 Democracy Blvd., 1 Democracy Plaza, Room 1078, MSC 4874, Bethesda, MD 20892–4874, 301–435–0807, glowaj@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research; 93.371, Biomedical Technology; 93.389, Research Infrastructure, 93.306, 93.333, National Institutes of Health, HHS) Dated: March 3, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–4565 Filed 3–10–08; 8:45 am] BILLING CODE 4140–01–M National Institutes of Health National Center for Research Resources; Notice of Closed Meetings DEPARTMENT OF HEALTH AND HUMAN SERVICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. National Institutes of Health Name of Committee: National Center for Research Resources Special Emphasis Panel K01 SEP—Teleconference. Date: March 31, 2008. Time: 10 a.m. to 12 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Room 1068, Bethesda, MD 20892. (Telephone Conference Call) Contact Person: John R. Glowa, PhD, Scientific Review Officer, National Center For Research Resources, or National Institutes of Health, 6701 Democracy Blvd., 1 Democracy Plaza, Room 1078, MSC 4874, Bethesda, MD 20892–4874, 301–435–0807, glowaj@mail.nih.gov. Name of Committee: National Center for Research Resources Special Emphasis Panel Human Tissue and Organ Program (HTOP) SEP. Date: April 1, 2008. Time: 2 p.m. to 4 p.m. PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel Advanced Development of Multivalent Filovirus (Ebola and Marburg) Hemorrhagic Fever Vaccines. Date: March 20, 2008. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate contract proposals. Place: Crowne Plaza Washington DC Silver Spring, 8777 Georgia Avenue, Silver Spring, MD 20910. Contact Person: Lynn Rust, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, (301) 402–3938, lr228v@nih.gov. E:\FR\FM\11MRN1.SGM 11MRN1

Agencies

[Federal Register Volume 73, Number 48 (Tuesday, March 11, 2008)]
[Notices]
[Page 13006]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-4565]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Research Resources; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

     Name of Committee: National Center for Research Resources 
Special Emphasis Panel K01 SEP--Teleconference.
     Date: March 31, 2008.
     Time: 10 a.m. to 12 p.m.
     Agenda: To review and evaluate grant applications.
     Place: National Institutes of Health, One Democracy Plaza, 6701 
Democracy Boulevard, Room 1068, Bethesda, MD 20892. (Telephone 
Conference Call)
     Contact Person: John R. Glowa, PhD, Scientific Review Officer, 
National Center For Research Resources, or National Institutes of 
Health, 6701 Democracy Blvd., 1 Democracy Plaza, Room 1078, MSC 
4874, Bethesda, MD 20892-4874, 301-435-0807, glowaj@mail.nih.gov.

     Name of Committee: National Center for Research Resources 
Special Emphasis Panel Human Tissue and Organ Program (HTOP) SEP.
     Date: April 1, 2008.
     Time: 2 p.m. to 4 p.m.
     Agenda: To review and evaluate grant applications.
     Place: National Institutes of Health, One Democracy Plaza, 6701 
Democracy Boulevard, Room 1068, Bethesda, MD 20892. (Telephone 
Conference Call)
     Contact Person: John R. Glowa, PhD, Scientific Review Officer, 
National Center for Research Resources, or National Institutes of 
Health, 6701 Democracy Blvd., 1 Democracy Plaza, Room 1078, MSC 
4874, Bethesda, MD 20892-4874, 301-435-0807, glowaj@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research; 93.371, Biomedical 
Technology; 93.389, Research Infrastructure, 93.306, 93.333, 
National Institutes of Health, HHS)

    Dated: March 3, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
 [FR Doc. E8-4565 Filed 3-10-08; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.